Metagenics Estrovera Perimenopause & Menopause Relief
Metagenics
USD$36.75
(No reviews yet)
Write a Review
Metagenics
Metagenics Estrovera Perimenopause & Menopause Relief
All-in-one plant-derived menopausal symptom relief in 1-4 weeks†*
Estrovera features ERr 731®, a plant-based and hormone-free ingredient clinically proven to relieve 12 of the most common symptoms of menopause by up to 83%.‡‡* Its proprietary nonestrogen formula works with a woman’s body to bring you back into balance naturally.
Benefits of Estrovera® Menopause Relief*
- Relieves hot flashes, night sweats, sleep disturbances, menopausal anxiety & more in 1-4 weeks††*
- Safe and #1 OBGYN recommended ingredient+
Supplement Facts
Estrovera 30 Tablets
| Ingredient | Amount Per Serving | % Daily Value |
|---|---|---|
| Serving Size | 1 Tablet | |
| Servings Per Container | 30 | |
| Rhapontic Rhubarb (Rheum rhaponticum L.) Root† Extract (ERr 731®) [Providing 2.2 mg rhaponticin and 1 mg desoxy-rhaponticin] | 4 mg | * |
Estrovera 90 Tablets
| Ingredient | Amount Per Serving | % Daily Value |
|---|---|---|
| Serving Size | 1 Tablet | |
| Servings Per Container | 90 | |
| Rhapontic Rhubarb (Rheum rhaponticum L.) Root† Extract (ERr 731®) [Providing 2.2 mg rhaponticin and 1 mg desoxy-rhaponticin] | 4 mg | * |
Other Ingredients:Microcrystalline cellulose, stearic acid (vegetable), croscarmellose sodium, silica, and enteric coating (ethyl cellulose, hydroxypropylmethylcellulose, medium-chain triglycerides, ammonium hydroxide, sodium alginate, hydroxypropylcellulose, oleic acid, and stearic acid).
Directions: Take one tablet with food and a glass of water once daily at the same time of day or as directed by your healthcare practitioner.
This product is non-GMO, gluten-free, and vegetarian.
Caution: Do not use if pregnant or nursing. If taking medication, consult your healthcare practitioner before use.
Storage: Keep tightly closed in a cool, dry place.
*Daily Value not established.
†Also known as Siberian rhubarb root.
+Research conducted by IQVIA for Metagenics.
††Survey conducted online by Metagenics March 2023 with 424 women currently or previously taking Estrovera.
‡Survey conducted online by Metagenics September 21 to October 5, 2020, with 75 women currently taking Estrovera.
‡‡Compared with perimenopausal women receiving placebo, those receiving ERr 731 (the extract found in Estrovera) experienced decreases in symptoms as indicated by the mean reduction in individual Menopause Rating Scale scores.
